Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases
This work is licensed under the Creative Commons Attribution 4.0 International License.
Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004; 58: 1496–505. doi: 10.1016/j.ijrobp.2003.09.024RickeJWustPStohlmannABeckAChoCHPechMCT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel techniqueInt J Radiat Oncol Biol Phys200458149650510.1016/j.ijrobp.2003.09.024Open DOISearch in Google Scholar
Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004; 15: 1279–86. doi: 10.1097/01.Rvi.0000141343.43441.06RickeJWustPWienersGBeckAChoCHSeidenstickerMLiver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablationJ Vasc Interv Radiol20041512798610.1097/01.Rvi.0000141343.43441.06Open DOISearch in Google Scholar
Seidensticker M, Wust P, Rühl R, Mohnike K, Pech M, Wieners G, et al. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol 2010; 5: 24. doi: 10.1186/1748-717x-5-24SeidenstickerMWustPRühlRMohnikeKPechMWienersGSafety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastasesRadiat Oncol201052410.1186/1748-717x-5-24Open DOISearch in Google Scholar
Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010; 78: 479–85. doi: 10.1016/j.ijrobp.2009.09.026RickeJMohnikeKPechMSeidenstickerMRühlRWienersGLocal response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapyInt J Radiat Oncol Biol Phys2010784798510.1016/j.ijrobp.2009.09.026Open DOISearch in Google Scholar
Wybranski C, Zeile M, Löwenthal D, Fischbach F, Pech M, Röhl FW, et al. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases. Radiat Oncol 2011; 6: 43. doi: 10.1186/1748-717x-6-43WybranskiCZeileMLöwenthalDFischbachFPechMRöhlFWValue of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastasesRadiat Oncol201164310.1186/1748-717x-6-43Open DOISearch in Google Scholar
Bretschneider T, Ricke J, Gebauer B, Streitparth F. Image-guided high-dose-rate brachytherapy of malignancies in various inner organs − technique, indications, and perspectives. J Contemp Brachytherapy 2016; 8: 251–61. doi: 10.5114/jcb.2016.61068BretschneiderTRickeJGebauerBStreitparthFImage-guided high-dose-rate brachytherapy of malignancies in various inner organs − technique, indications, and perspectivesJ Contemp Brachytherapy201682516110.5114/jcb.2016.61068Open DOISearch in Google Scholar
Omari J, Drewes R, Orthmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, inter-stitial brachytherapy as second-line or salvage therapy. Diagn IntervRradiol 2019; 25: 360–7. doi: 10.5152/dir.2019.18390OmariJDrewesROrthmerMHassPPechMPowerskiMTreatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, inter-stitial brachytherapy as second-line or salvage therapyDiagn IntervRradiol201925360710.5152/dir.2019.18390Open DOISearch in Google Scholar
Chow DH, Sinn LH, Ng KK, Lam CM, Yuen J, Fan ST, et al. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study. J Surg Oncol 2006; 94: 565–71. doi: 10.1002/jso.20674ChowDHSinnLHNgKKLamCMYuenJFanSTRadiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative studyJ Surg Oncol2006945657110.1002/jso.20674Open DOISearch in Google Scholar
Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159: 591–9. doi: 10.2214/ajr.159.3.1503032Le BihanDTurnerRDouekPPatronasNDiffusion MR imaging: clinical applicationsAJR Am J Roentgenol1992159591910.2214/ajr.159.3.1503032Open DOISearch in Google Scholar
Dudeck O, Zeile M, Wybranski C, Schulmeister A, Fischbach F, Pech M, et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol 2010; 20: 2699–706. doi: 10.1007/s00330-010-1846-zDudeckOZeileMWybranskiCSchulmeisterAFischbachFPechMEarly prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapyEur Radiol201020269970610.1007/s00330-010-1846-zOpen DOISearch in Google Scholar
Welsh JS, Kennedy AS, Thomadsen B. Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006; 66(2 Suppl): S62–73. doi: 10.1016/j.ijrobp.2005.09.011WelshJSKennedyASThomadsenBSelective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinomaInt J Radiat Oncol Biol Phys2006662 SupplS627310.1016/j.ijrobp.2005.09.011Open DOISearch in Google Scholar
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52–60. doi: 10.1055/s-0030-1247132LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis201030526010.1055/s-0030-1247132Open DOISearch in Google Scholar
Kim MN, Kim BK, Han KH, Kim SU. Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment. Expert Rev Gastroenterol Hepatol 2015; 9: 335–48. doi: 10.1586/17474124.2015.959929KimMNKimBKHanKHKimSUEvolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessmentExpert Rev Gastroenterol Hepatol201593354810.1586/17474124.2015.959929Open DOISearch in Google Scholar
Vouche M, Kulik L, Atassi R, Memon K, Hickey R, Ganger D, et al. Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: imaging analysis from a prospective randomized trial of Y90 ± Sorafenib. Hepatology 2013; 58: 1655–66. doi: 10.1002/hep.26487VoucheMKulikLAtassiRMemonKHickeyRGangerDRadiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: imaging analysis from a prospective randomized trial of Y90 ± SorafenibHepatology20135816556610.1002/hep.26487Open DOISearch in Google Scholar
Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol 2006; 9: 125–32. doi: 10.1053/j.tvir.2007.02.004VossenJABuijsMKamelIRAssessment of tumor response on MR imaging after locoregional therapyTech Vasc Interv Radiol200691253210.1053/j.tvir.2007.02.004Open DOISearch in Google Scholar
Ludwig JM, Camacho JC, Kokabi N, Xing M, Kim HS. The role of diffusion-weighted imaging (DWI) in Locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers. Diagnostics 2015; 5: 546–63. doi: 10.3390/diagnostics5040546LudwigJMCamachoJCKokabiNXingMKimHSThe role of diffusion-weighted imaging (DWI) in Locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkersDiagnostics201555466310.3390/diagnostics5040546Open DOISearch in Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47. doi: 10.1016/j.ejca.2008.10.026EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer2009452284710.1016/j.ejca.2008.10.026Open DOISearch in Google Scholar
Hamm B, Thoeni RF, Gould RG, Bernardino ME, Lüning M, Saini S, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417–23. doi: 10.1148/radiology.190.2.8284392HammBThoeniRFGouldRGBernardinoMELüningMSainiSFocal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imagingRadiology19941904172310.1148/radiology.190.2.8284392Open DOISearch in Google Scholar
Ishida K, Tamura A, Kato K, Uesugi N, Osakabe M, Eizuka M, et al. Correlation between CT morphologic appearance and histologic findings in colorectal liver metastasis after preoperative chemotherapy. Abdom Radiol (NY) 2018; 43: 2991–3000. doi: 10.1007/s00261-018-1588-yIshidaKTamuraAKatoKUesugiNOsakabeMEizukaMCorrelation between CT morphologic appearance and histologic findings in colorectal liver metastasis after preoperative chemotherapyAbdom Radiol (NY)2018432991300010.1007/s00261-018-1588-yOpen DOISearch in Google Scholar
Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622–35. doi: 10.2214/ajr.06.1403KohDMCollinsDJDiffusion-weighted MRI in the body: applications and challenges in oncologyAJR Am J Roentgenol200718816223510.2214/ajr.06.1403Open DOISearch in Google Scholar
Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and per-fusion in neurologic disorders. Radiology 1986; 161: 401–7. doi: 10.1148/radiology.161.2.3763909Le BihanDBretonELallemandDGrenierPCabanisELaval-JeantetMMR imaging of intravoxel incoherent motions: application to diffusion and per-fusion in neurologic disordersRadiology1986161401710.1148/radiology.161.2.3763909Open DOISearch in Google Scholar
Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248: 894–900. doi: 10.1148/radiol.2483071407CuiYZhangXPSunYSTangLShenLApparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastasesRadiology200824889490010.1148/radiol.2483071407Open DOISearch in Google Scholar
Eccles CL, Haider EA, Haider MA, Fung S, Lockwood G, Dawson LA. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol 2009; 48: 1034–43. doi: 10.1080/02841860903099972EcclesCLHaiderEAHaiderMAFungSLockwoodGDawsonLAChange in diffusion weighted MRI during liver cancer radiotherapy: preliminary observationsActa Oncol20094810344310.1080/02841860903099972Open DOISearch in Google Scholar
Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001–8. doi: 10.2214/ajr.06.0601KohDMScurrECollinsDKanberBNormanALeachMOPredicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficientsAJR Am J Roentgenol20071881001810.2214/ajr.06.0601Open DOISearch in Google Scholar
Marugami N, Tanaka T, Kitano S, Hirohashi S, Nishiofuku H, Takahashi A, et al. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging. Cardiovasc Intervent Radiol 2009; 32: 638–46. doi: 10.1007/s00270-009-9532-8MarugamiNTanakaTKitanoSHirohashiSNishiofukuHTakahashiAEarly detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imagingCardiovasc Intervent Radiol2009326384610.1007/s00270-009-9532-8Open DOISearch in Google Scholar
Schraml C, Schwenzer NF, Clasen S, Rempp HJ, Martirosian P, Claussen CD, et al. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 2009; 29: 1308–16. doi: 10.1002/jmri.21770SchramlCSchwenzerNFClasenSRemppHJMartirosianPClaussenCDNavigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial resultsJ Magn Reson Imaging20092913081610.1002/jmri.21770Open DOISearch in Google Scholar
Schmeel FC, Simon B, Luetkens JA, Traber F, Meyer C, Schmeel LC, et al. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol 2017; 143: 1531–41. doi: 10.1007/s00432-017-2395-5SchmeelFCSimonBLuetkensJATraberFMeyerCSchmeelLCPrognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolizationJ Cancer Res Clin Oncol201714315314110.1007/s00432-017-2395-5Open DOISearch in Google Scholar
Lahrsow M, Albrecht MH, Bickford MW, Vogl TJ. Predicting treatment response of colorectal cancer liver metastases to conventional lipiodol-based transarterial chemoembolization using diffusion-weighted MR imaging: value of pretreatment apparent diffusion coefficients (ADC) and ADC changes under therapy. Cardiovasc Intervent Radiol 2017; 40: 852–9. doi: 10.1007/s00270-017-1634-0LahrsowMAlbrechtMHBickfordMWVoglTJPredicting treatment response of colorectal cancer liver metastases to conventional lipiodol-based transarterial chemoembolization using diffusion-weighted MR imaging: value of pretreatment apparent diffusion coefficients (ADC) and ADC changes under therapyCardiovasc Intervent Radiol201740852910.1007/s00270-017-1634-0Open DOISearch in Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344–9. doi: 10.1016/j.jclinepi.2007.11.008von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJ Clin Epidemiol200861344910.1016/j.jclinepi.2007.11.008Open DOISearch in Google Scholar
Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 2010; 78: 172–9. doi: 10.1016/j.ijrobp.2009.07.1700MohnikeKWienersGSchwartzFSeidenstickerMPechMRuehlRComputed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survivalInt J Radiat Oncol Biol Phys201078172910.1016/j.ijrobp.2009.07.1700Open DOISearch in Google Scholar
Ingenerf MK, Karim H, Fink N, Ilhan H, Ricke J, Treitl KM, et al. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol 2022; 63: 877–88. doi: 10.1177/02841851211024004IngenerfMKKarimHFinkNIlhanHRickeJTreitlKMApparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility studyActa Radiol2022638778810.1177/02841851211024004Open DOISearch in Google Scholar
Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991; 180: 327–32. doi: 10.1148/radiology.180.2.2068294OutwaterETomaszewskiJEDalyJMKresselHYHepatic colorectal metastases: correlation of MR imaging and pathologic appearanceRadiology19911803273210.1148/radiology.180.2.2068294Open DOISearch in Google Scholar
Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging 2012; 35: 1365–71. doi: 10.1002/jmri.23589Curvo-SemedoLLambregtsDMMaasMBeetsGLCaseiro-AlvesFBeets-TanRGDiffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressivenessJ Magn Reson Imaging20123513657110.1002/jmri.23589Open DOISearch in Google Scholar
Liu Z, Fan JM, He C, Li ZF, Xu YS, Li Z, et al. Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis. Cancer Imaging 2020; 20: 3. doi: 10.1186/s40644-019-0282-9LiuZFanJMHeCLiZFXuYSLiZUtility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysisCancer Imaging202020310.1186/s40644-019-0282-9Open DOISearch in Google Scholar